drug study MMMC
-
Upload
kathleen-intalan -
Category
Documents
-
view
238 -
download
0
Transcript of drug study MMMC
-
8/7/2019 drug study MMMC
1/14
DRUG STUDY
GENERIC
NAME/BRANDNAME
DOSA
GE/ROUTE
CLASSIFICATI
ON
INDICATION CONTRAINDICATI
ON
ADVERSE
REACTIONS
NURSING
RESPONSIBILITIES
Genericname:
Allopurinol
Brandname:
LLANOL
100
mg OD
GoutPreparations
Primaryuncomplicatedhyperurecemia;mild gout; severetophaceous gout;uric acidnephropathy; uricacid nephrolithiasis;and in the
prevention of renalCalcium oxalatestones.
Allopurinolshould bediscontinued atthe firstappearance ofrash or anysign that mayindicate anallergic
reaction,painfulurination, bloodin the urine,irritation of theeyes, orswelling of thelips or mouth
Allopurinolmay increasethe frequencyof acute goutyattacks duringthe first 6-12months oftherapy.Prophylacticdoses ofcolchicineshouldtherefore beadministered
allergic skinreactions, GIdisturbances,diarrhea, and jointpain
monitor serum uricacid levels to evaluatedrugs effectiveness
monitor fluidintake and output; dailyurine output of at least 2liters and maintenance ofneutral or slightly alkalineurine are desirable
periodically
monitor CBC and hepaticand renal function,especially at start oftherapy, as ordered
If renalinsufficiency occurs at anytime during treatment, beprepared to reducedosage, as ordered.
Optimal benefitsmay require 2-6 weeks oftherapy. Because acutegouty attacks occur during
this time, concurrent use ofcolchicines may beprescribed prophylactically.
To minimize GIdisturbance, tell patient totake with or immediatelyafter meals.
Encourage thepatient to drink plenty offluids while taking this drugunless otherwisecontraindicated.
-
8/7/2019 drug study MMMC
2/14
concurrentlyduring the first3 - 6 months ofallopurinoltherapy.
Drowsinessmay occurduringallopurinoltherapy andmay impairone's ability toperformactivitiesrequiringmentalalertness.
Liverfunction tests(particularly inpatients withpreexistingliver disease),renal functiontests(particularly inpatients withimpaired renalfunction), and
complete bloodcell countsshould beperformedduring the firstfew months.Reduce thedosage ofallopurinol ortotally
Drug may causedrowsiness, tell patient notto drive or performhazardous tasks requiringmental alertness until CNSeffects of the drug are
known. If the patient istaking allopurinol fortreatment of recurrentcalcium oxalate stones,advise him to also reducehis dietary intake of animalprotein, sodium, refinedsugars, oxalate-rich foods,and calcium.
Tell patient todiscontinue at first sign ofrash, which may precedesevere hypersensitivity orother adverse reaction.Rash is more common inpatient taking diuretics andin those with renaldisorders. Tell the patientto report all adversereactions.
-
8/7/2019 drug study MMMC
3/14
discontinue thedrug ifevidence ofdeterioration inrenal function
occurs andpersists.
Allopurinolis rarelyindicated inchildren exceptin those withhyperuricemiasecondary toneoplasticdisease, cancerchemotherapy,
or geneticdisorders ofpurinemetabolism.
The effectof allopurinolon the humanfetus is notknown, and thedrug should beused duringpregnancy only
when clearlyneeded.
Sinceallopurinol andoxypurinol aredistributed intomilk, allopurinolshould be usedwith caution in
-
8/7/2019 drug study MMMC
4/14
nursing women.GenericName:budesonide
andformoterolinhalation
BrandNames:Symbicort
160mg neb
Corticosteroids
regular treatment ofasthma where useof a combination
(inhaledcorticosteroid andlong acting beta 2agonist) isappropriate
Hypersensitivity toinhaled lactose
Abdominalpain,conjunctivitis
(pinkeye), cough,
diarrhea,
ear infectionorinflammation,
fever,
fungalinfection inmouth,
headache,
nasal or sinusinflammation,
nosebleed,
pain, rash,
respiratoryinfection,
stomach orintestinalinflammation,
throatinflammation,
viralinfection,
vomiting,
wheezing
Taper systemicsteroids carefullyduring transfer to
inhalational steroids;deaths from adrenalinsufficiency haveoccurred.
Arrange for use ofdecongestant nosedrops to facilitatepenetration ifedema, excessivesecretions arepresent.
Prime unit beforeuse for PulmicortTurbuhaler; havepatient rinse mouthafter each use.
Use aerosol within6 mo of opening.Shake well beforeeach use.
Store Respulesupright andprotected from light;gently shake beforeuse; open envelopesshould be discardedafter 2 wk.
Generic Bronchodilators management of Hypertrophic Fine tremor of Use nebulizer
-
8/7/2019 drug study MMMC
5/14
name:ALBUTEROLSULFATEIPRATROPIUM BROMIDE
Brandname:Combivent
Nebq6
reversiblebronchospasmassociated withobstructive airwaydiseases in patients
who require morethan a singlebronchodilator
obstructivecardiomyopathy ortachyarrhythmia.History ofhypersensitivity to
soya lecithin orrelated foodproducts (for MDIonly).
skeletal muscle;palpitations;headache, dizziness,nervousness; drynessof mouth, throat
irritation; urinaryretention
mouthpiece instead offace mask to avoidblurred vision oraggravation of narrow-angle glaucoma.
Can mix albuterol innebulizer for up to 1hr. Ensure adequatehydration, controlenvironmentaltemperature toprevent hyperpyrexia. Have patient voidbefore takingmedication to avoidurinary retention.
Teach patient properuse of inhalator.
Brandname:Micardistablet
40mg/tabOD
Angiotensin IIAntagonists
Treatment ofessentialhypertension.
biliary obstructivedisorders, severehepaticimpairment.
Headache, upperresp tract infection,dizziness, fatigue.
Check the doctorsorder beforeadministering themedication.
Follow the 10 rightsof medicationadministration.
Observe proper handhygiene in givingmedications.
Instruct patient toget help ifunnecessary conditionhappens.
Inform the patientabout certain sideeffects.
Instruct the patientto inform the healthcare provider if
http://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Angiotensin%20II%20Antagonists&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Angiotensin%20II%20Antagonists&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=companionhome&ID=1169http://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Angiotensin%20II%20Antagonists&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Angiotensin%20II%20Antagonists&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=companionhome&ID=1169 -
8/7/2019 drug study MMMC
6/14
condition does notimprove or if feelscondition does notchange.
Brandname:EssentialeFortecapsule
1 capbidAfterBPandaftersupper
Cholagogues,Cholelitholytics& HepaticProtectors
Acute and ChronicHepatitis: Dystrophyand cirrhosis of theliver, biliary stasisand hepatic coma.
Liver Damaged byToxins: Fatty liver(eg, in diabetes,tuberculosis andchronicrheumatism),
prophylaxis ofrecurrentgallstones, radiationdamage, nephroticsyndrome andgestoses.
No knowncontraindication
Abdominal pain,nausea, allergicreaction
Check the doctorsorder beforeadministering themedication.
Follow the 10 rightsof medicationadministration.
Observe proper handhygiene in givingmedications.
Instruct patient toget help if
unnecessary conditionhappens.
Inform the patientabout certain sideeffects.
Instruct the patientto inform the healthcare provider ifcondition does notimprove or if feelscondition does notchange.
Fenoflexcapsule 1 tab
3x aweek
DyslipidaemicAgents Treatment of types
IIa, IIb, III, IV & Vhyperlipoproteinemias.
Severe renaldysfunction,hepaticdysfunction egprimary biliarycirrhosis &unexplainedpersistent liverfunction,
Abdominal painback pain,headache,flu syndrome;abnormal liverfunction test,diarrhea,nausea, constipation;increased ALT, CPK &
For dilution ofsolution forintravenousinduction electrolytesolutions should notbe used.
Follow the 10 rights
http://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Cholagogues%2C%20Cholelitholytics%20%26%20Hepatic%20Protectors&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Cholagogues%2C%20Cholelitholytics%20%26%20Hepatic%20Protectors&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Cholagogues%2C%20Cholelitholytics%20%26%20Hepatic%20Protectors&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Cholagogues%2C%20Cholelitholytics%20%26%20Hepatic%20Protectors&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=companionhome&ID=527http://www.mims.com/Page.aspx?menuid=companionhome&ID=925http://www.mims.com/Page.aspx?menuid=companionhome&ID=1597http://www.mims.com/Page.aspx?menuid=companionhome&ID=1597http://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Dyslipidaemic%20Agents&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Dyslipidaemic%20Agents&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Cholagogues%2C%20Cholelitholytics%20%26%20Hepatic%20Protectors&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Cholagogues%2C%20Cholelitholytics%20%26%20Hepatic%20Protectors&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Cholagogues%2C%20Cholelitholytics%20%26%20Hepatic%20Protectors&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=companionhome&ID=527http://www.mims.com/Page.aspx?menuid=companionhome&ID=925http://www.mims.com/Page.aspx?menuid=companionhome&ID=1597http://www.mims.com/Page.aspx?menuid=companionhome&ID=1597http://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Dyslipidaemic%20Agents&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Dyslipidaemic%20Agents&CTRY=PH -
8/7/2019 drug study MMMC
7/14
preexistinggallbladderdisease.
AST; rhinitis. of medicationadministration.
Inform the patientabout certain sideeffects.
Omeproncapsule 20mg
cap 1tabbafterBP
Antacids,AntirefluxAgents &Antiulcerants
converted to activemetabolites thatirreversibly bindand inhibit H+-K+-ATPase (an enzymeon the surface ofgastric parietalcells). It inhibitstransport ofhydrogen ions into
the gastric lumen.Omeprazoleincreases thegastric pH andreduces gastric acidformation.
Symptomaticresponse toomeprazoletherapy does notrule out thepresence of agastricmalignancy.Atrophic gastritishas been noted
occasionally ingastric corpusbiopsies frompatients on long-term omeprazoletherapy.
Headache
Diarrhea
Abdominalpain
Nausea
Dizziness
Asthenia (lossof strength)
Vomiting
Constipation Upper
respiratorytract infection
Back pain
Rash
Cough
Give before meals
Do not crush orchew tablets, swallowwhole
Evaluate fortherapeutic responselike relief ofGastrointestinalsymptoms
Question if
Gastrointestinaldiscomfort, nausea,and diarrhea occurs.
SenokotTab
2 tab1tabHS asneces
saryforconstipation
Laxatives,Purgatives
Functionalconstipation ofhospitalized patient,O & G patient, post-
surgical, prenatal,postpartum,geriatric patient,functionalconstipation due tointake of certaindrugs, ped patient.
Acute surgicalabdomen,abdominal pain,nausea, vomiting
or symptoms ofappendicitis;intestinalhemorrhage orobstruction,persistentdiarrhea.
Mild abdominaldiscomfort; diarrheaw/ excessive loss ofwater & electrolytes
(high doses),
Assess baseline ofelimination.
Teach the patient how
to self administerlaxative.
Encourage patientnormalize bowelmovement.
Avamys Nasal Treatment of nasal back pain, cough, Check the doctors
http://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Antacids%2C%20Antireflux%20Agents%20%26%20Antiulcerants&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Antacids%2C%20Antireflux%20Agents%20%26%20Antiulcerants&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Antacids%2C%20Antireflux%20Agents%20%26%20Antiulcerants&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Antacids%2C%20Antireflux%20Agents%20%26%20Antiulcerants&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Laxatives%2C%20Purgatives&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Laxatives%2C%20Purgatives&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=companionhome&ID=539http://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Nasal%20Decongestants%20%26%20Other%20Nasal%20Preparations&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Antacids%2C%20Antireflux%20Agents%20%26%20Antiulcerants&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Antacids%2C%20Antireflux%20Agents%20%26%20Antiulcerants&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Antacids%2C%20Antireflux%20Agents%20%26%20Antiulcerants&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Laxatives%2C%20Purgatives&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Laxatives%2C%20Purgatives&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=companionhome&ID=539http://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Nasal%20Decongestants%20%26%20Other%20Nasal%20Preparations&CTRY=PH -
8/7/2019 drug study MMMC
8/14
nasal spray 2sprayeachnostrilOD
Decongestants& Other NasalPreparations
& ocular symptomsofseasonal &perennial allergicrhinitis.
headache, minornosebleed, nasalsore, or sorethroat.
Epistaxis, nasalulceration.
order beforeadministering themedication.
Follow the 10 rightsof medication
administration. Observe proper handhygiene in givingmedications.
Instruct patient toget help ifunnecessary conditionhappens.
Inform the patientabout certain sideeffects.
Instruct the patient
to inform the healthcare provider ifcondition does notimprove or if feelscondition does notchange.
Montelukast (kastair) 10mg
OD
Antiasthmatic& COPDPreparations
Treatment ofbronchial asthma,allergic rhinitisconcomitant to
bronchial asthma &allergic rhinitis.
Do not use fortreatment of acuteasthma attacks.
Rash, angio-edema,pruritus & urticaria.Dizziness, headache,dream abnomalities,hallucinations,
agitation includingaggressive behavior,paresthesia/hypoesthesia, drowsiness,insomnia, irritability,restlessness.Somnolence,dyspepsia, infectiousgastroenteritis,diarrhea, nausea &
Do not use thismedication if you areallergic tomontelukast.
Before usingmontelukast, tell yourdoctor if you areallergic to any drugs(especially aspirin).You may need a doseadjustment or specialtests to safely use thismedication.
http://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Nasal%20Decongestants%20%26%20Other%20Nasal%20Preparations&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Nasal%20Decongestants%20%26%20Other%20Nasal%20Preparations&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Nasal%20Decongestants%20%26%20Other%20Nasal%20Preparations&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=companionhome&ID=2021http://www.mims.com/Page.aspx?menuid=companionhome&ID=2021http://www.mims.com/Page.aspx?menuid=companionhome&ID=2021http://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Antiasthmatic%20%26%20COPD%20Preparations&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Antiasthmatic%20%26%20COPD%20Preparations&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Antiasthmatic%20%26%20COPD%20Preparations&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=companionhome&ID=2716http://www.mims.com/Page.aspx?menuid=companionhome&ID=78http://www.mims.com/Page.aspx?menuid=companionhome&ID=2716http://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Nasal%20Decongestants%20%26%20Other%20Nasal%20Preparations&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Nasal%20Decongestants%20%26%20Other%20Nasal%20Preparations&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=companionhome&ID=2021http://www.mims.com/Page.aspx?menuid=companionhome&ID=2021http://www.mims.com/Page.aspx?menuid=companionhome&ID=2021http://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Antiasthmatic%20%26%20COPD%20Preparations&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Antiasthmatic%20%26%20COPD%20Preparations&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Antiasthmatic%20%26%20COPD%20Preparations&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=companionhome&ID=2716http://www.mims.com/Page.aspx?menuid=companionhome&ID=78http://www.mims.com/Page.aspx?menuid=companionhome&ID=2716 -
8/7/2019 drug study MMMC
9/14
vomiting. Nasalcongestion, cough,influenza, upper respinfection, increasedserum alanine &
aspartateaminotransferase,pyuria.Asthenia/fatigue,myalgia, fever,trauma, dental &abdominal pain.
Take this medicationexactly as it wasprescribed for you. Donot take themedication in larger
amounts, or take it forlonger thanrecommended by yourdoctor. Follow thedirections on yourprescription label.
Ansimar 400mg tab 2xa day
Antiasthmatic& COPDPreparations
Bronchial asthma &pulmonary diseasew/ spastic bronchialcomponent.
Acute MI,hypotension,
Nausea, vomiting,epigastric pain,cephalalgia,irritability, insomnia,tachycardia,
extrasystole,tachypnea,
Use with caution inpatients withhypoxemia,hyperthyroidism,liver disease, renal
disease, in thosewith history of pepticulcer and in elderly.Frequently, patientswith CHF havemarkedly prolongeddrug serum levelsfollowingdiscontinuation ofAnsimar.
assess for allergic
reactionassess for breathsounds
should be given to apregnant womanonly if clearlyneeded.
Hydrocortis Corticosteroid Allergic states: Viral/fungal Muscle wasting, Establish
http://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Antiasthmatic%20%26%20COPD%20Preparations&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Antiasthmatic%20%26%20COPD%20Preparations&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Antiasthmatic%20%26%20COPD%20Preparations&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=companionhome&ID=2716http://www.mims.com/Page.aspx?menuid=companionhome&ID=3003http://www.mims.com/Page.aspx?menuid=companionhome&ID=3206http://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Corticosteroid%20Hormoneshttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Antiasthmatic%20%26%20COPD%20Preparations&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Antiasthmatic%20%26%20COPD%20Preparations&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Antiasthmatic%20%26%20COPD%20Preparations&CTRY=PHhttp://www.mims.com/Page.aspx?menuid=companionhome&ID=2716http://www.mims.com/Page.aspx?menuid=companionhome&ID=3003http://www.mims.com/Page.aspx?menuid=companionhome&ID=3206http://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Corticosteroid%20Hormones -
8/7/2019 drug study MMMC
10/14
one 100mg IVq8
Hormones / EyeCorticosteroids/ TopicalCorticosteroids
Control of severe orincapacitatingallergic conditionsintractable toadequate trials of
conventionaltreatment inasthma, atopicdermatitis, contactdermatitis, drughypersensitivityreactions, perennialor seasonal allergicrhinitis, serumsickness,transfusionreactions.
Gastrointestinaldiseases: To tidethe patient over acritical period of thedisease in regionalenteritis (systemictherapy) andulcerative colitis.
Hematologic
disorders:Acquired(autoimmune)hemolytic anemia,
infections,tubercular orsyphilitic lesions,bacterial infectionsunless used in
conjunction withappropriatechemotherapy.
weakness,osteoporosis. GIdisturbances andbleeding. Increasedappetite and delayed
wound healing.Bruising, striae,hirsutism, acne,flushing. Raisedintracranial pressure,headache,depression,psychosisHyperglycaemia,glycosuria, DM,obesity, moon-face,buffalo hump.
Suppression ofpituitary-adrenocorticalsystem.
baseline andcontinuing dataon BP, weight,fluid andelectrolyte
balance, andblood glucose.
Lab tests:Periodic serumelectrolytesblood glucose,Hct and Hgb,platelet count,and WBC withdifferential.
Monitor foradverse effects.
Older adultsand patientswith low serumalbumin areespeciallysusceptible toadverse effects.
Be alert to signsof hypocalcemia(see AppendixF).
Ophthalmoscopi
c examinationsarerecommendedevery 23 mo,especially ifpatient isreceivingophthalmicsteroid therapy.
Monitor for
http://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Corticosteroid%20Hormoneshttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Eye%20Corticosteroidshttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Eye%20Corticosteroidshttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Topical%20Corticosteroidshttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Topical%20Corticosteroidshttp://www.rxlist.com/script/main/art.asp?articlekey=2373http://www.rxlist.com/script/main/art.asp?articlekey=9692http://www.rxlist.com/script/main/art.asp?articlekey=9692http://www.rxlist.com/script/main/art.asp?articlekey=20442http://www.rxlist.com/script/main/art.asp?articlekey=20442http://www.rxlist.com/script/main/art.asp?articlekey=5280http://www.rxlist.com/script/main/art.asp?articlekey=5280http://www.rxlist.com/script/main/art.asp?articlekey=5695http://www.rxlist.com/script/main/art.asp?articlekey=5695http://www.rxlist.com/script/main/art.asp?articlekey=7370http://www.rxlist.com/script/main/art.asp?articlekey=3695http://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Corticosteroid%20Hormoneshttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Eye%20Corticosteroidshttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Eye%20Corticosteroidshttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Topical%20Corticosteroidshttp://www.mims.com/Page.aspx?menuid=mimssearch&searchcategory=THERAPEUTIC&searchstring=Topical%20Corticosteroidshttp://www.rxlist.com/script/main/art.asp?articlekey=2373http://www.rxlist.com/script/main/art.asp?articlekey=9692http://www.rxlist.com/script/main/art.asp?articlekey=9692http://www.rxlist.com/script/main/art.asp?articlekey=20442http://www.rxlist.com/script/main/art.asp?articlekey=20442http://www.rxlist.com/script/main/art.asp?articlekey=5280http://www.rxlist.com/script/main/art.asp?articlekey=5280http://www.rxlist.com/script/main/art.asp?articlekey=5695http://www.rxlist.com/script/main/art.asp?articlekey=5695http://www.rxlist.com/script/main/art.asp?articlekey=7370http://www.rxlist.com/script/main/art.asp?articlekey=3695 -
8/7/2019 drug study MMMC
11/14
persistentbackache orchest pain;compressionand
spontaneousfractures oflong bones andvertebraepresenthazards.
Monitor for andreport changesin mood andbehavior,emotionalinstability, or
psychomotoractivity,especially withlong-termtherapy.
Be alert topossibility ofmaskedinfection anddelayed healing(antiinflammatory and
immunosuppressive actions).
Note: Doseadjustment maybe required ifpatient issubjected tosevere stress(seriousinfection,
-
8/7/2019 drug study MMMC
12/14
surgery, orinjury).
Note: Singledoses ofcorticosteroids
or use for ashort period(
-
8/7/2019 drug study MMMC
13/14
improve or if feelscondition does notchange.
arcoxia
4mg1 tabOD
NonsteroidalAnti-inflammatoryDrugs
Acute & chronic
treatment of thesigns & symptomsosteoarthritis & RA.Treatment ofankylosingspondylitis.Treatment of acutegouty arthritis &primarydysmenorrhea.Relief of acute &chronic pain.
History of
hypersensitivity toetoricoxib or to anyof the excipients ofArcoxia.
Active pepticulceration or activeGI bleeding.
Patients who haveexperiencedbronchospasm,
acute rhinitis,nasal polyps,angioneuroticedema, urticaria orallergic-typereactions aftertakingacetylsalicylic acidor NSAIDsincludingcyclooxygenase-2(COX-2) inhibitors.
Establishedischemic heartdisease, peripheralarterial diseaseand/orcerebrovasculardisease.
Immune System
Disorders:Hypersensitivityreactions includinganaphylactic/anaphylactoid reactions.
Psychiatric Disorders:Anxiety, insomnia,confusion,hallucinations.
Nervous System
Disorders: Dysgeusia.
Cardiac Disorders:Congestive heartfailure.
Vascular Disorders:Hypertensive crisis.
Respiratory, Thoracicand Mediastinal
Disorders:Bronchospasm.
GastrointestinalDisorders: Abdominalpain, oral ulcers,peptic ulcersincluding perforationand bleeding (mainlyin the elderly),
Check the doctors
order beforeadministering themedication.
Follow the 10 rightsof medicationadministration.
Observe proper handhygiene in givingmedications.
Instruct patient toget help ifunnecessary condition
happens. Inform the patientabout certain sideeffects.
Instruct the patientto inform the healthcare provider ifcondition does notimprove or if feelscondition does notchange.
http://www.mims.com/Page.aspx?menuid=companionhome&ID=1669http://www.mims.com/Page.aspx?menuid=companionhome&ID=2698http://www.mims.com/Page.aspx?menuid=companionhome&ID=2698http://www.mims.com/Page.aspx?menuid=companionhome&ID=987http://www.mims.com/Page.aspx?menuid=companionhome&ID=1692http://www.mims.com/Page.aspx?menuid=companionhome&ID=1669http://www.mims.com/Page.aspx?menuid=companionhome&ID=2698http://www.mims.com/Page.aspx?menuid=companionhome&ID=2698http://www.mims.com/Page.aspx?menuid=companionhome&ID=987http://www.mims.com/Page.aspx?menuid=companionhome&ID=1692 -
8/7/2019 drug study MMMC
14/14
vomiting, pruritus,rash, urticaria,diarrhea.
HepatobiliaryDisorders: Hepatitis:
Skin andSubcutaneous TissueDisorders:Angioedema, rash,pruritus, Stevens-Johnson syndrome,urticaria.
Renal and UrinaryDisorders: Renalinsufficiencyincluding renalfailure, usuallyreversible upondiscontinuation oftherapy (seePrecautions)